Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 86, Issue 2, 2009, Pages 96-103

  Wagner, Julie ^a   Allen, Nancy A ^b   Swalley, Leah M ^b   Melkus, Gail D ^c   Whittemore, Robin ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b YALE UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Depression; Glucose; Insulin resistance; Insulin sensitivity; Physical activity

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; GLUCOSE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROMOTION; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; REFERENCE VALUE; SELF REPORT;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CONNECTICUT; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCOME; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; MIDDLE AGED; PATIENT SELECTION; PREGNANCY; RISK FACTORS; SUBURBAN POPULATION; URBAN POPULATION; YOUNG ADULT;

EID: 70349770535     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.06.024     Document Type: Article

References (50)

1. CDC, National diabetes fact sheet: general information and national estimates on diabetes in the United States, http://www.cdc.gov/diabetes/pubs/factsheet05.htm (accessed on February 1, 2007).
2. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 346 (2002) 393-403
3. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344 (2001) 1343-1350
4. Morrison J.A., Glueck C.J., Horn P.S., Schreiber G.B., and Wang P. Pre-teen insulin resistance predicts weight gain, impaired fasting glucose, and type 2 diabetes at age 18-19 y: a 10-y prospective study of black and white girls. American Journal of Clinical Nutrition 88 (2008) 778-788
5. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care 30 (2007) 318-324
6. Ioannou G.N., Bryson C.L., and Boyko E.J. Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes. Journal of Diabetes & its Complications 21 (2007) 363-370
7. Hawley J.A. Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes/Metabolism Research Reviews 20 (2004) 383-393
8. Adriaanse M.C., Dekker J.M., Nijpels G., Heine R.J., Snoek F.J., and Pouwer F. Associations between depressive symptoms and insulin resistance: the Hoorn Study. Diabetologia 49 (2006) 2874-2877
9. Pan A., Ye X., Franco O.H., Li H., Yu Z., Zou S., et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. Journal of Affective Disorders 109 (2008) 75-82
10. Okamura F., Tashiro A., Utumi A., Imai T., Suchi T., Tamura D., et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism: Clinical & Experimental 49 (2000) 1255-1260
11. Weber-Hamann B., Gilles M., Lederbogen F., Heuser I., and Deuschle M. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. Journal of Clinical Psychiatry 67 (2006) 1856-1861
12. Weber-Hamann B., Gilles M., Schilling C., Onken V., Frankhauser P., Kopf D., et al. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. Journal of Clinical Psychopharmacology 28 (2008) 581-584
13. Lustman P.J., Clouse R.E., Nix B.D., Freedland K.E., Rubin E.H., McGill J.B., et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Archives of General Psychiatry 63 (2006) 521-529
14. Arroyo C., Hu F.B., Ryan L.M., Kawachi I., Colditz G.A., Speizer F.E., et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 27 (2004) 129-133
15. Carnethon M.R., Kinder L.S., Fair J.M., Stafford R.S., and Fortmann S.P. Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. American Journal of Epidemiology 158 (2003) 416-423
16. Brown L.C., Majumdar S.R., Newman S.C., Johnson J.A., Brown L.C., Majumdar S.R., et al. History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care 28 (2005) 1063-1067
17. Eaton W.W., Armenian H., Gallo J., Pratt L., and Ford D.E. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 19 (1996) 1097-1102
18. Knol M.J., Twisk J.W., Beekman A.T., Heine R.J., Snoek F.J., Pouwer F., et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49 (2006) 837-845
19. Cosgrove M.P., Sargeant L.A., and Griffin S.J. Does depression increase the risk of developing type 2 diabetes?. Occupational Medicine (Oxford) 58 (2008) 7-14
20. Herva A., Rasanen P., Miettunen J., Timonen M., Laksy K., Veijola J., et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosomatic Medicine 68 (2006) 213-216
21. Lawlor D.A., Smith G.D., and Ebrahim S. Association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health Study. BMJ 327 (2003) 1383-1384
22. Kauffman R.P., Castracane V.D., White D.L., Baldock S.D., and Owens R. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age. Gynecological Endocrinology 21 (2005) 129-137
23. Rubin R.R., Ma Y., Marrero D.G., Peyrot M., Barrett-Connor E.L., Kahn S.E., et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 31 (2008) 420-426
24. Saydah S.H., Brancati F.L., Golden S.H., Fradkin J., and Harris M.I. Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes/Metabolism Research Reviews 19 (2003) 202-208
25. Everson-Rose S.A., Meyer P.M., Powell L.H., Pandey D., Torrens J.I., Kravitz H.M., et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 27 (2004) 2856-2862
26. Andersohn F., Schade S., Suissa S., and Garb E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. American Journal of Psychiatry 166 (2009) 591-598
27. American, Diabetes, Association, Diabetes risk test, http://www.diabetes.org/risk-test (accessed on October 1, 2005).
28. A. American Diabetes. Standards of medical care in diabetes--2008. Diabetes Care 31 Suppl. 1 (2008) S12-54
29. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
30. Shaibi G.Q., Davis J., Weigensberg M.J., Roberts C.K., and Goran M.I. Homeostasis model assessment does not detect improvements in insulin resistance following and intervention in overweight youth: a comparison to whole-body insulin sensitivity measures. Diabetes 57 (2008) A68
31. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1 (1977) 385-401
32. Weissman M.M., Sholomskas D., Pottenger M., Prusoff B.A., and Locke B.Z. Assessing depressive symptoms in five psychiatric populations: a validation study. American Journal of Epidemiology 106 (1977) 203-214
33. Lewinsohn P.M., Seeley J.R., Roberts R.E., and Allen N.B. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychology & Aging 12 (1997) 277-287
34. Walker S.N., Sechrist K.R., and Pender N.J. The Health-Promoting Lifestyle Profile: development and psychometric characteristics. Nursing Research 36 (1987) 76-81
35. Jefferson V.W., Melkus G.D., and Spollett G.R. Health-promotion practices of young black women at risk for diabetes. Diabetes Educator 26 (2000) 295-302
36. Timonen M., Rajala U., Jokelainen J., Keinanen-Kiukaanniemi S., Meyer-Rochow V.B., and Rasanen P. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort. Molecular Psychiatry 11 (2006) 929-933
37. Weber B., Schweiger U., Deuschle M., and Heuser I. Major depression and impaired glucose tolerance. Experimental & Clinical Endocrinology & Diabetes 108 (2000) 187-190
38. Suarez E.C. Sex differences in the relation of depressive symptoms, hostility, and anger expression to indices of glucose metabolism in nondiabetic adults. Health Psychology 25 (2006) 484-492
39. Potter van Loon B.J., Radder J.K., Frolich M., Krans H.M., Zwinderman A.H., and Meinders A.E. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 16 (1992) 79-85
40. Park S., and Choi S.B. Does fluoxetine administration influence insulin resistance in 90% pancreatectomized rats?. Metabolism: Clinical & Experimental 51 (2002) 38-43
41. Chen Y., Shen Y., Hung Y., Chao-Ha C., Yeh C., and Perng C. Comparison of glucose-insulin homeostasis following maprotiline and fluoxetine in depressed males. Journal of Affective Disorders 103 (2007) 257-261
42. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosomatic Medicine 59 (1997) 241-250
43. Ramasubbu R. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Medical Hypotheses 59 (2002) 537-551
44. Sachar E.J., Hellman L., Roffwarg H.P., Halpern F.S., Fukushima D.K., and Gallagher T.F. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Archives of General Psychiatry 28 (1973) 19-24
45. Greden J.F., Albala A.A., Haskett R.F., James N.M., Goodman L., Steiner M., et al. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. Biological Psychiatry 15 (1980) 449-458
46. Kiecolt-Glaser J.K., and Glaser R. Depression and immune function: central pathways to morbidity and mortality. Journal of Psychosomatic Research 53 (2002) 873-876
47. Moller D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends in Endocrinology & Metabolism 11 (2000) 212-217
48. Horacek J., Kuzmiakova M., Hoschl C., Andel M., and Bahbonh R. The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers. Psychoneuroendocrinology 24 (1999) 785-797
49. Gilles M., Wilke A., Kopf D., Nonell A., Lehnert H., Deuschle M., et al. Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: implications for atypical antipsychotics. Psychosomatic Medicine 67 (2005) 748-751
50. Lin E.H., Katon W., Von Korff M., Rutter C., Simon G.E., Oliver M., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27 (2004) 2154-2160